Valneva
About:
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
Website: http://www.valneva.com
Twitter/X: valnevase
Top Investors: Pfizer, Bpifrance, OrbiMed, Deerfield, Deep Track Capital
Description:
Valneva is a pharmaceutical company developing prophylactic vaccines to treat infectious diseases. The company focused on developing and commercializing prophylactic vaccines for infectious diseases with significant unmet medical needs. Valneva has leveraged its expertise and capabilities both to commercialize two vaccines successfully and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus, and COVID-19.
$854M
$100M to $500M
Saint-herblain, Pays de la Loire, France
2013-01-01
bd(AT)valneva.com
501-1000
2024-09-13
Public
© 2025 bioDAO.ai